Drug Discovery Technologies Market, By Drug Type, By Technology, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

Description

Drug Discovery Technologies Market size was valued at USD 43,506.1 Million in 2025, expanding to a CAGR of 11.3% from 2026 to 2033.

Drug discovery technologies are the scientific methods, digital technologies and research platforms used to identify and develop potential new medicines. They are essential in the drug development pipeline where they help scientists find biological targets associated with diseases, screen large libraries of compounds and optimize potential drugs for further testing. These technologies facilitate key activities like understanding disease mechanisms, evaluating drug effectiveness etc.

Drug Discovery Technologies Market- Market Dynamics

Rising demand for treatment of disease such as cancer, neurological disorders and rapid developments in genomics are expected to propel market demand

Pharmaceutical and biotechnology companies are striving to bring new treatments to market faster and more efficiently, which is driving the solid growth of the drug discovery technologies market. Increasing burden of chronic and complex diseases such as cancer, neurological disorders, autoimmune diseases and rare genetic diseases is resulting in increased demand for innovative approaches to drug discovery. Traditional drug discovery methods are usually time-consuming, expensive, and associated with high development risks, prompting organizations to adopt more advanced and data-driven technologies. Modern discovery platforms help researchers identify biological targets, screen potential compounds, and optimize drug candidates with greater speed and accuracy. Also, the growing focus on precision medicine and patient-specific treatments is encouraging wider adoption of sophisticated discovery tools.

The demand for genomics that is fast changing and provides a better understanding of the genetic factors that influence disease development and response to treatment is supplementing the growth of the drug discovery technologies market. Genomics is also accelerating the trend toward precision medicine, where treatments are made for personalized therapies. Growing interest in personalized therapies among healthcare providers and pharmaceutical companies to meet the rising demand for advanced drug discovery platforms that can analyze genomic data is fueling the market. Consequently, pharmaceutical and biotechnology companies are investing more and more in technologies that can analyze and interpret complex genetic information to identify novel therapeutic targets. The availability of large-scale genomic databases and bioinformatics tools has opened up new avenues for data-driven drug discovery. Genomics is predominantly valuable in areas such as oncology, rare diseases, and inherited disorders, where understanding genetic mechanisms is critical for treatment development. In addition, genomic research is increasing the need for sophisticated drug discovery technologies, boosting drug discovery technologies market growth.

Drug Discovery Technologies Market- Segmentation Analysis:

The Global Drug Discovery Technologies Market is segmented on the basis of Drug Type, Technology, Application, End-Use, and Region.

The market is divided into six categories based on Drug Type: biologics, small molecule drugs, cell & gene therapies, vaccines, protein & peptide drugs, and others. The small molecule drugs segment represented a substantial revenue share in the drug type. Drug discovery technologies are critical for the development of small molecule drugs and support important functions such as target validation, compound screening, molecular modelling, rational drug design and candidate optimization. Pharma companies continue to spend a lot of research dollars on small molecule programs for multiple reasons including their proven therapeutic effectiveness, well-established development pathways, ease of administration, etc.

Drug Discovery Technologies Market- Geographical Insights

In Asia-Pacific region, countries including China, India, South Korea, and Japan are making substantial investments in pharmaceutical research and biotechnology capabilities. The adoption of advanced drug discovery technologies is being supported by expanding research infrastructure, increased healthcare spending, and an increasing number of clinical and translational research programs. A large patient population and a growing scientific talent pool, combined with government initiatives to promote life sciences innovation, are increasing research by domestic and international companies.

In Latin America and the Middle East & Africa, the market is developing steadily as healthcare systems evolve and scientific research capabilities continue to improve. Further, rising capital funding for biomedical research, greater focus on healthcare innovation, and expanding participation in international research collaborations are fueling the need for drug discovery technologies.

Mexico Drug Discovery Technologies Market- Key Insights

Mexico is gaining major attention in the drug discovery technologies market as its pharmaceutical industry continues to expand and investments in biomedical research increase. Stronger collaboration between local organizations and global life sciences companies is helping strengthen the country's research capabilities and support the development of innovative therapies. a growing number of biotechnology startups are contributing to the advancement of drug discovery by adopting modern tools such as computational biology, molecular simulation, and data-driven research platforms. These technologies enable researchers to identify promising drug candidates more efficiently and accelerate early-stage development activities. Thus, improving research productivity will increase the adoption of advanced drug discovery solutions.

Drug Discovery Technologies Market- Competitive Landscape:

The drug discovery technologies market is formulated by intense competition as technology providers, pharmaceutical companies, and biotechnology firms emphasize on novel drug development. Companies are developing platforms that can analyze complex biological and chemical datasets, and support faster decision-making during early-stage research. Additionally, advances in genomics, and multi-omics research are encouraging companies to improve their discovery platforms with more sophisticated analytical capabilities. Thus, expanding research, new drug discovery is shaping the competitive landscape of the drug discovery technologies market.

Recent Developments:

In January 2025, Owkin launched Owkin K1.0 Turbigo, an AI-enabled platform developed to enhance drug discovery, therapeutic development, and diagnostic research. The solution combines advanced artificial intelligence models with intelligent digital agents to generate biological insights, streamline research workflows, and support more efficient decision-making.

In January 2025, Absci and Owkin formed a strategic collaboration to bolster AI-driven drug discovery capabilities. The partnership combines Owkin's artificial intelligence-based target identification expertise with Absci's generative AI technology for biologics design.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET KEY PLAYERS

Thermo Fisher Scientific
Danaher Corporation
Agilent Technologies
PerkinElmer
Bio-Rad Laboratories
Illumina
Waters Corporation
Bruker Corporation
Charles River Laboratories
Evotec SE
Schrodinger
Certara
IQVIA
Benchling
Recursion Pharmaceuticals
Owkin
Others

GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2020-2033

Biologics
Small molecule drugs
Cell & gene therapies
Vaccines
Protein & peptide drugs
Others

GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020-2033

High-Throughput Screening (HTS)
Genomics and Proteomics Technologies
Combinatorial Chemistry
Computational Drug Discovery
Pharmacogenomics
Others

GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2020-2033

Neurology
Cardiovascular Diseases
Infectious Diseases
Immunology and Autoimmune Disorders
Oncology
Others

GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033

Pharmaceutical & Biotech Companies
Contract Research Organizations (CROs)
Academic Research
Others

GLOBAL DRUG DISCOVERY TECHNOLOGIES MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Denmark
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Taiwan
Vietnam
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Iran
Qatar
Rest of MEA

Product Code: ANV6884

1. Drug Discovery Technologies Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Drug Discovery Technologies Market Snippet by Drug Type
- 2.1.2. Drug Discovery Technologies Market Snippet by Technology
- 2.1.3. Drug Discovery Technologies Market Snippet by Application
- 2.1.4. Drug Discovery Technologies Market Snippet by End-Use
- 2.1.5. Drug Discovery Technologies Market Snippet by Country
- 2.1.6. Drug Discovery Technologies Market Snippet by Region
2.2. Competitive Insights

3. Drug Discovery Technologies Key Market Trends

3.1. Drug Discovery Technologies Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Drug Discovery Technologies Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Drug Discovery Technologies Market Opportunities
3.4. Drug Discovery Technologies Market Future Trends

4. Drug Discovery Technologies Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Drug Discovery Technologies Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Drug Discovery Technologies Market Landscape

6.1. Drug Discovery Technologies Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Drug Discovery Technologies Market - By Drug Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Drug Type, 2025 & 2033 (%)
- 7.1.2. Biologics
- 7.1.3. Small molecule drugs
- 7.1.4. Cell & gene therapies
- 7.1.5. Vaccines
- 7.1.6. Protein & peptide drugs
- 7.1.7. Others

8. Drug Discovery Technologies Market - By Technology

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
- 8.1.2. High-Throughput Screening (HTS)
- 8.1.3. Genomics and Proteomics Technologies
- 8.1.4. Combinatorial Chemistry
- 8.1.5. Computational Drug Discovery
- 8.1.6. Pharmacogenomics
- 8.1.7. Others

9. Drug Discovery Technologies Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 9.1.2. Neurology
- 9.1.3. Cardiovascular Diseases
- 9.1.4. Infectious Diseases
- 9.1.5. Immunology and Autoimmune Disorders
- 9.1.6. Oncology
- 9.1.7. Others

10. Drug Discovery Technologies Market - By End-Use

10.1. Overview
- 10.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
- 10.1.2. Pharmaceutical & Biotech Companies
- 10.1.3. Contract Research Organizations (CROs)
- 10.1.4. Academic Research
- 10.1.5. Others

11. Drug Discovery Technologies Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Drug Discovery Technologies Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Drug Discovery Technologies Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.3.17. Rest of Europe
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.3.17.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Drug Discovery Technologies Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Drug Discovery Technologies Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Drug Discovery Technologies Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Drug Type, 2020 - 2033 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Drug Discovery Technologies Industry

12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Thermo Fisher Scientific
- 12.2.2. Danaher Corporation
- 12.2.3. Agilent Technologies
- 12.2.4. PerkinElmer
- 12.2.5. Bio-Rad Laboratories
- 12.2.6. Illumina
- 12.2.7. Waters Corporation
- 12.2.8. Bruker Corporation
- 12.2.9. Charles River Laboratories
- 12.2.10. Evotec SE
- 12.2.11. Schrodinger
- 12.2.12. Certara
- 12.2.13. IQVIA
- 12.2.14. Benchling
- 12.2.15. Recursion Pharmaceuticals
- 12.2.16. Owkin
- 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us